Eventide Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.6M | Sell |
384,231
-147,961
| -28% | -$6.39M | 0.29% | 103 |
|
|
2025
Q1 | $18.4M | Hold |
532,192
| – | – | 0.37% | 89 |
|
|
2024
Q4 | $14.6M | Sell |
532,192
-184,735
| -26% | -$5.07M | 0.27% | 115 |
|
|
2024
Q3 | $18.3M | Hold |
716,927
| – | – | 0.31% | 93 |
|
|
2024
Q2 | $18.2M | Hold |
716,927
| – | – | 0.31% | 95 |
|
|
2024
Q1 | $22.2M | Hold |
716,927
| – | – | 0.35% | 83 |
|
|
2023
Q4 | $28.9M | Hold |
716,927
| – | – | 0.47% | 63 |
|
|
2023
Q3 | $18.9M | Sell |
716,927
-224,249
| -24% | -$5.91M | 0.34% | 87 |
|
|
2023
Q2 | $16.2M | Hold |
941,176
| – | – | 0.27% | 98 |
|
|
2023
Q1 | $15.6M | Buy |
+941,176
| New | +$15.6M | 0.29% | 96 |
|
|
2021
Q3 | – | Sell |
-712,197
| Closed | -$43.4M | – | 153 |
|
|
2021
Q2 | $43.4M | Hold |
712,197
| – | – | 0.58% | 56 |
|
|
2021
Q1 | $43.9M | Buy |
+712,197
| New | +$43.9M | 0.65% | 59 |
|